Quarterly report pursuant to Section 13 or 15(d)

Going Concern (Details Narrative)

v3.19.1
Going Concern (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 4 Months Ended 9 Months Ended
Nov. 02, 2018
Jan. 31, 2018
Jan. 31, 2019
Jan. 31, 2018
Oct. 31, 2017
Oct. 31, 2016
Jan. 31, 2019
Jan. 31, 2018
Dec. 27, 2018
Apr. 30, 2018
Apr. 30, 2017
Cash   $ 8,373,535 $ 3,193,548 $ 8,373,535     $ 3,193,548 $ 8,373,535   $ 7,646,279 $ 6,820,623
Working capital     3,200,000       3,200,000        
Accumulated deficit     (24,783,857)       (24,783,857)     $ (18,228,552)  
Cash used in operating activities             (4,631,603) (6,261,637)      
Net proceeds from sales of common stock             178,872 2,590,004      
Proceeds from convertible preferred stock and warrants             4,918,620      
Gross sales              
Shares issued price per share     $ 1.36       $ 1.36   $ 0.92    
ATM Agreement [Member]                      
Net proceeds from sales of common stock             $ 178,872        
Gross sales $ 1,000,000                  
Commission rate 3.00%                    
Common stock sold             235,071        
Net issuance costs             $ 60,330        
Shares issued price per share     $ 1.02       $ 1.02        
Private Placement [Member]                      
Net proceeds from sales of common stock         $ 2,600,000            
Private Placement [Member] | Series B Convertible Preferred Stock and Series C Convertible Preferred Stock [Member]                      
Proceeds from convertible preferred stock           $ 10,900,000          
Private Placement [Member] | Series E Preferred Stock [Member]                      
Proceeds from convertible preferred stock and warrants   $ 4,900,000